Create an account to read this article
You need to create an account to read this article.
Create Account Sign in
Urology
Nephrology
Cardiology and CTVS
Changed Policy For Use Of Erythropoietin Stimulating Agents Has Lowered MACE In Kidney Failure Patients
0 Comments
Post a comment
No comments yet. Be the first to comment!